Rob Lipschutz PhD
Chairman of Board of Directors, Consultant
Rob Lipshutz is a co-founder of PreCyte and served as CEO until November 2019. He brings over 25 years of experience in molecular diagnostics and business development. He served as SVP of corporate development at Affymetrix and CBO at Institute for Systems Biology. At Affymetrix, he led commercialization and first FDA-approval of Dx microarrays and led four acquisitions.